drugset / Trial / NCT06066008
Safety and Efficacy Study of Novel Gene Therapy ZM-01 for X-linked Retinoschisis Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This trial is meant to evaluate the safety and efficacy of ZM-01 of X-linked retinoschisis. Unilateral intravitreal injections (IVT) will be given into the subject's Study Eye.
Timeline
- Start
- 2022-09-25
- Primary completion
- 2023-10-31
- Completion
- 2026-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZM-01 | Unknown | — | Intravitreal |